- Home
- FNLC vs QTRX Comparison
FNLC vs QTRX Comparison
Compare FNLC & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- QTRX
- Stock Information
- Founded
- FNLC 1864
- QTRX 2007
- Country
- FNLC United States
- QTRX United States
- Employees
- FNLC N/A
- QTRX N/A
- Industry
- FNLC Major Banks
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- FNLC Finance
- QTRX Industrials
- Exchange
- FNLC Nasdaq
- QTRX Nasdaq
- Market Cap
- FNLC 263.4M
- QTRX 233.5M
- IPO Year
- FNLC 1999
- QTRX 2017
- Fundamental
- Price
- FNLC $24.47
- QTRX $5.28
- Analyst Decision
- FNLC
- QTRX Buy
- Analyst Count
- FNLC 0
- QTRX 5
- Target Price
- FNLC N/A
- QTRX $16.20
- AVG Volume (30 Days)
- FNLC 16.1K
- QTRX 609.1K
- Earning Date
- FNLC 04-23-2025
- QTRX 05-12-2025
- Dividend Yield
- FNLC 5.88%
- QTRX N/A
- EPS Growth
- FNLC 1.70
- QTRX N/A
- EPS
- FNLC 2.52
- QTRX N/A
- Revenue
- FNLC $82,116,000.00
- QTRX $137,421,000.00
- Revenue This Year
- FNLC N/A
- QTRX $5.22
- Revenue Next Year
- FNLC N/A
- QTRX $15.31
- P/E Ratio
- FNLC $9.70
- QTRX N/A
- Revenue Growth
- FNLC 5.28
- QTRX 12.30
- 52 Week Low
- FNLC $22.11
- QTRX $4.67
- 52 Week High
- FNLC $31.05
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- FNLC 51.45
- QTRX 41.90
- Support Level
- FNLC $24.17
- QTRX $5.21
- Resistance Level
- FNLC $25.00
- QTRX $5.75
- Average True Range (ATR)
- FNLC 0.58
- QTRX 0.41
- MACD
- FNLC 0.10
- QTRX 0.04
- Stochastic Oscillator
- FNLC 56.56
- QTRX 21.09
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.